Business Context and Reporting Period
Company: Blue Water Acquisition Corp. III (BLUW)
Reporting Period: Year ended December 31, 2025 (Inception: November 1, 2024)
Business Type: Cayman Islands exempted company (SPAC) with no material operations. The Company was formed to effect a Business Combination, primarily targeting biotechnology, healthcare, and technology sectors.
Key Events:
- Initial Public Offering (IPO): Consummated on June 11, 2025, selling 25,300,000 Units at $10.00 per unit, generating gross proceeds of $253,000,000.
- Private Placement: Simultaneous sale of 683,000 Private Placement Units for $6,830,000.
- Sponsor Change: On November 25, 2025, the "Prior Sponsor" sold all Founder Shares and Private Placement Units to the "New Sponsor" (Yorkville BW Acquisition Sponsor, LLC) for $7,200,000. The entire Board and management team were replaced effective this date.
- Trust Account: $253,000,000 deposited in trust at IPO. As of December 31, 2025, the balance grew to $258,796,563 due to interest income.
Key Financial Metrics
| Metric | Value (Year Ended Dec 31, 2025) |
|---|---|
| Revenue | $0 (No operating revenue) |
| Net Income | $4,667,721 |
| Total Operating Expenses | $1,128,842 |
| Interest Income (Trust Account) | $5,796,563 |
| Cash in Trust Account | $258,796,563 |
| Cash Outside Trust | $0 |
| Working Capital Deficiency | ($109,004) |
| Deferred Underwriting Fees | $8,855,000 (Liability) |
| Shares Outstanding (Class A Public) | 25,300,000 |
| Shares Outstanding (Class B Founder) | 6,325,000 |
Material Changes vs. Prior Period
The Company was in its inception phase for the period ended December 31, 2024, with no IPO proceeds. The 2025 period reflects the full impact of the IPO and subsequent operations:
- Revenue/Income: Shifted from a net loss of $48,541 in 2024 to a net income of $4,667,721 in 2025, driven entirely by interest income earned on the Trust Account ($5.8M).
- Assets: Total assets increased from $25,000 (2024) to $258,910,967 (2025), primarily due to the Trust Account balance.
- Liabilities: Current liabilities increased to $190,149, and a non-current deferred underwriting fee liability of $8,855,000 was recorded.
- Management: Complete turnover of the Board of Directors and executive officers in November 2025 following the sale of the Sponsorship.
Guidance, Outlook, Risks, and Unusual Items
Outlook and Liquidity:
- Going Concern: The independent auditor has expressed substantial doubt about the Company's ability to continue as a going concern. The Company has no cash outside the Trust Account and a working capital deficiency.
- Financing: On January 26, 2026 (subsequent to period end), the Company issued a $500,000 convertible Working Capital Note to the New Sponsor to fund operations.
- Deadline: The Company must complete a Business Combination within 24 months of the IPO (by June 2027) or liquidate.
Risks and Contingencies:
- Internal Controls: The Company identified a material weakness in internal control over financial reporting related to a lack of properly designed controls.
- Geopolitical Risks: Significant exposure to global conflicts (Russia-Ukraine, Middle East) and trade policy changes (tariffs) which could impact target selection and valuation.
- Trust Account Claims: Funds in the Trust Account could be subject to claims by creditors, potentially reducing the redemption value below $10.00 per share.
- Investment Company Act: Risk of being deemed an unregistered investment company if the Trust Account holds securities for too long; the Company currently holds funds in cash to mitigate this.
Unusual Items:
- Sponsor Transition: The sale of the Sponsorship for $7.2M (vs. original $25k cost) created a significant profit for the Prior Sponsor and introduced a new management team with different incentives.
- CEO Advisory Fee: A monthly advisory fee of $15,000 was approved for the new CEO, accrued but unpaid as of year-end.
Investor Verification Checklist
- Going Concern Status: Verify the sufficiency of the $500,000 Working Capital Note issued in January 2026 to sustain operations until a Business Combination or liquidation.
- Internal Control Remediation: Review the specific remediation plan for the material weakness in internal controls identified in the 2025 audit.
- Trust Account Composition: Confirm that the Trust Account remains invested in cash or permitted short-term securities to avoid Investment Company Act classification.
- Sponsor Indemnification: Assess the financial capacity of the New Sponsor to indemnify the Trust Account against third-party claims, as the Company notes the Sponsor's assets are primarily Company securities.
- Redemption Rights: Understand that public shareholders may redeem shares for approximately $10.00 plus interest if no Business Combination is completed by the deadline.